Hepatitis E Diagnostic Tests Market by Type and Application- Global Industry Analysis & Forecast to 2027

Published On : January 2021 Pages : 152 Category: Healthcare IT Report Code : HC0115273

Hepatitis E Diagnostic Tests Market By Type (ELISA HEV IgM Test kits, ELISA HEV IgG Test Kits, and RT-PCR Test Kits) and Application (Hospitals, Diagnostic Laboratories, Research Centers, and Point of Care)- Global Industry Analysis & Forecast to 2027

Industry Outlook and Trend Analysis

The Hepatitis E Diagnostic Tests Market has encountered significant development over the recent years and is anticipated to grow tremendously over the forecast period.is a common cause of enterically-transmitted acute hepatitis in developing countries.The commonly used tests for HEV infection include detection of IgM and IgG anti-HEV antibodies and detection of HEV RNA. IgM anti-HEV antibodies can be detected during the first few months after HEV infection, whereas IgG anti-HEV antibodies represent either recent or remote exposure.

Drivers and Restraints

Top-down and bottom-up approaches are used to validate the global Hepatitis E Diagnostic Tests Market and estimate the market size for company, regions segments, type segments and applications (end users). In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.

Regional Insights

The data for 2021 is an estimate, based on the history data and the integrated view of industry experts, manufacturers, distributors and end users etc.

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Italy
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • India
    • Southeast Asia
    • Rest of Asia-Pacific
  • SouthAmerica
    • Brazil
    • Argentina
    • Columbia
    • Rest of South America
  • Middle East and Africa
    • Saudi Arabia
    • UAE
    • Egypt
    • Nigeria
    • South Africa
    • Turkey
    • Rest of MEA

Competitive Analysis                         

The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.

  • Altona Diagnostics GmbH
  • Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
  • Biokit S.A.
  • Dia.Pro - Diagnostic Bioprobess.r.l, F. Hoffmann-La Roche Ltd.
  • Fast-track diagnostics Ltd.
  • Fortress Diagnostics Limited
  • MikrogenGmBH
  • MP Biomedicals
  • Primerdesign Ltd.

Some of the key questions answered by the report are:

  • What was the market size in 2017 and forecast from 2021 to 2027?
  • What will be the industry market growth from 2017 to 2027?
  • What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
  • What are the major segments leading the market growth and why?
  • Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?

Market Classification

·         Hepatitis E Diagnostic Tests Market, ByType, Estimates and Forecast, 2017-2027 ($Million)

o    ELISA HEV IgM Test kits

o    ELISA HEV IgG Test Kits

o    RT-PCR Test Kits

·         Hepatitis E Diagnostic Tests Market, ByApplication, Estimates and Forecast, 2017-2027 ($Million)

o    Hospitals

o    Diagnostic Laboratories

o    Research Centers

o    Point of Care

·         Hepatitis E Diagnostic Tests Market, By Key Players, Estimates and Forecast, 2017-2027 ($Million)

o    Altona Diagnostics GmbH

o    Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.

o    Biokit S.A.

o    Dia.Pro - Diagnostic Bioprobess.r.l

o    F. Hoffmann-La Roche Ltd.

o    Fast-track diagnostics Ltd.

o    Fortress Diagnostics Limited

o    MikrogenGmBH

o    MP Biomedicals

o    Primerdesign Ltd

·         Hepatitis E Diagnostic Tests Market, By Region, Estimates and Forecast, 2017-2027 ($Million)

o    North America

§  North America Hepatitis E Diagnostic Tests Market, By Country

o    U.S. Hepatitis E Diagnostic Tests Market

o    Canada Hepatitis E Diagnostic Tests Market

o    Mexico Hepatitis E Diagnostic Tests Market

o    Europe

§  Europe Hepatitis E Diagnostic Tests Market, By Country

o    UK Hepatitis E Diagnostic Tests Market

o    Germany Hepatitis E Diagnostic Tests Market

o    France Hepatitis E Diagnostic Tests Market

o    Russia Hepatitis E Diagnostic Tests Market

o    Italy Hepatitis E Diagnostic Tests Market

o    Rest of Europe Hepatitis E Diagnostic Tests Market

o    Asia-Pacific

§  Asia-Pacific Hepatitis E Diagnostic Tests Market, By Country

o    China Hepatitis E Diagnostic Tests Market

o    Japan Hepatitis E Diagnostic Tests Market

o    South Korea Hepatitis E Diagnostic Tests Market

o    India Hepatitis E Diagnostic Tests Market

o    Southeast Asia Hepatitis E Diagnostic Tests Market

o    Rest of Asia-Pacific Hepatitis E Diagnostic Tests Market

o    South America

§  South America Hepatitis E Diagnostic Tests Market

o    Brazil Hepatitis E Diagnostic Tests Market

o    Argentina Hepatitis E Diagnostic Tests Market

o    Columbia Hepatitis E Diagnostic Tests Market

o    Rest of South America Hepatitis E Diagnostic Tests Market

o    Middle East and Africa

§  Middle East and Africa Hepatitis E Diagnostic Tests Market

o    Saudi Arabia Hepatitis E Diagnostic Tests Market

o    UAE Hepatitis E Diagnostic Tests Market

o    Egypt Hepatitis E Diagnostic Tests Market

o    Nigeria Hepatitis E Diagnostic Tests Market

o    South Africa Hepatitis E Diagnostic Tests Market

o    TurkeyHepatitis E Diagnostic Tests Market

o    Rest of MEA Hepatitis E Diagnostic Tests Market

Table of Contents:

1.       Introduction

1.1.     Report Description

2.       Executive Summary

2.1.     Key Highlights

3.       Market Overview

3.1.     Introduction

3.1.1.  Market Definition

3.1.2.  Market Segmentation

3.2.     Market Dynamics

3.2.1.  Drivers

3.2.2.  Restraints

3.2.3.  Opportunities

4.       Market Analysis by Regions

4.1.     North America (United States, Canada and Mexico)

4.1.1.  United States Market Status and Outlook (2017-2027)

4.1.2.  Canada Market Status and Outlook (2017-2027)

4.1.3.  Mexico Market Status and Outlook (2017-2027)

4.2.     Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

4.2.1.  Germany Market Status and Outlook (2017-2027)

4.2.2.  France Market Status and Outlook (2017-2027)

4.2.3.  UK Market Status and Outlook (2017-2027)

4.2.4.  Russia Market Status and Outlook (2017-2027)

4.2.5.  Italy Market Status and Outlook (2017-2027)

4.2.6.  Rest of Europe Market Status and Outlook (2017-2027)

4.3.     Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)

4.3.1.  China Market Status and Outlook (2017-2027)

4.3.2.  Japan Market Status and Outlook (2017-2027)

4.3.3.  Korea Market Status and Outlook (2017-2027)

4.3.4.  India Market Status and Outlook (2017-2027)

4.3.5.  Southeast Asia Market Status and Outlook (2017-2027)

4.3.6.  Rest of Asia-Pacific Market Status and Outlook (2017-2027)

4.4.     South America (Brazil, Argentina, Columbia and Rest of South America)

4.4.1.  Brazil Market Status and Outlook (2017-2027)

4.4.2.  Argentina Market Status and Outlook (2017-2027)

4.4.3.  Columbia Market Status and Outlook (2017-2027)

4.4.4.  Rest of South America Market Status and Outlook (2017-2027)

4.5.     Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)

4.5.1.  Saudi Arabia Market Status and Outlook (2017-2027)

4.5.2.  United Arab Emirates Market Status and Outlook (2017-2027)

4.5.3.  Egypt Market Status and Outlook (2017-2027)

4.5.4.  Nigeria Market Status and Outlook (2017-2027)

4.5.5.  South Africa Market Status and Outlook (2017-2027)

4.5.6.  Turkey Market Status and Outlook (2017-2027)

4.5.7.  Rest of Middle East and Africa Market Status and Outlook (2017-2027)

5.       Hepatitis E Diagnostic Tests  Market, By Type

5.1.     Introduction

5.2.     Global Hepatitis E Diagnostic Tests  Revenue and Market Share by Type (2017-2021)

5.2.1.  Global Hepatitis E Diagnostic Tests  Revenue and Revenue Share by Type (2017-2021)

5.3.     ELISA HEV IgM Test kits

5.3.1.  Global ELISA HEV IgM Test kits Revenue and Growth Rate (2017-2021)

5.4.     ELISA HEV IgG Test Kits

5.4.1.  Global ELISA HEV IgG Test Kits Revenue and Growth Rate (2017-2021)

5.5.     RT-PCR Test Kits

5.5.1.  Global RT-PCR Test Kits Revenue and Growth Rate (2017-2021)

6.       Hepatitis E Diagnostic Tests  Market, By Applications

6.1.     Introduction

6.2.     Global Hepatitis E Diagnostic Tests  Revenue and Market Share by Applications (2017-2021)

6.2.1.  Global Hepatitis E Diagnostic Tests  Revenue and Revenue Share by Applications (2017-2021)

6.3.     Hospitals

6.3.1.  Global Hospitals Revenue and Growth Rate (2017-2021)

6.4.     Diagnostic Laboratories

6.4.1.  Global Diagnostic Laboratories Revenue and Growth Rate (2017-2021)

6.5.     Research Centers

6.5.1.  Global Research Centers Revenue and Growth Rate (2017-2021)

6.6.     Point of Care

6.6.1.  Global Point of Care Revenue and Growth Rate (2017-2021)

7.       Hepatitis E Diagnostic Tests  Market, By Region

7.1.     Introduction

7.2.     Global Hepatitis E Diagnostic Tests  Revenue and Market Share by Regions

7.2.1.  Global Hepatitis E Diagnostic Tests  Revenue by Regions (2017-2021)

7.3.     North America Hepatitis E Diagnostic Tests  by Countries

7.3.1.  North America Hepatitis E Diagnostic Tests  Revenue and Growth Rate (2017-2021)

7.3.2.  North America Hepatitis E Diagnostic Tests  Revenue (Million USD) by Countries (2017-2021)

7.3.3.  United States

7.3.3.1.  United States Hepatitis E Diagnostic Tests  Revenue (Millions USD) and Growth Rate (2017-2021)

7.3.4.  Canada

7.3.4.1.  Canada Hepatitis E Diagnostic Tests  Revenue (Millions USD) and Growth Rate (2017-2021)

7.3.5.  Mexico

7.3.5.1.  Mexico Hepatitis E Diagnostic Tests  Revenue (Millions USD) and Growth Rate (2017-2021)

7.4.     Europe Hepatitis E Diagnostic Tests  by Countries

7.4.1.  Europe Hepatitis E Diagnostic Tests  Revenue and Growth Rate (2017-2021)

7.4.2.  Europe Hepatitis E Diagnostic Tests  Revenue (Million USD) by Countries (2017-2021)

7.4.3.  Germany

7.4.3.1.  Germany Hepatitis E Diagnostic Tests  Revenue (Millions USD) and Growth Rate (2017-2021)

7.4.4.  France

7.4.4.1.  France Hepatitis E Diagnostic Tests  Revenue (Millions USD) and Growth Rate (2017-2021)

7.4.5.  UK

7.4.5.1.  UK Hepatitis E Diagnostic Tests  Revenue (Millions USD) and Growth Rate (2017-2021)

7.4.6.  Russia

7.4.6.1.  Russia Hepatitis E Diagnostic Tests  Revenue (Millions USD) and Growth Rate (2017-2021)

7.4.7.  Italy

7.4.7.1.  Italy Hepatitis E Diagnostic Tests  Revenue (Millions USD) and Growth Rate (2017-2021)

7.4.8.  Rest of Europe

7.4.8.1.  Rest of Europe Hepatitis E Diagnostic Tests  Revenue (Millions USD) and Growth Rate (2017-2021)

7.5.     Asia-Pacific Hepatitis E Diagnostic Tests  by Countries

7.5.1.  Asia-Pacific Hepatitis E Diagnostic Tests  Revenue and Growth Rate (2017-2021)

7.5.2.  Asia-Pacific Hepatitis E Diagnostic Tests  Revenue (Million USD) by Countries (2017-2021)

7.5.3.  China

7.5.3.1.  China Hepatitis E Diagnostic Tests  Revenue (Millions USD) and Growth Rate (2017-2021)

7.5.4.  Japan

7.5.4.1.  Japan Hepatitis E Diagnostic Tests  Revenue (Millions USD) and Growth Rate (2017-2021)

7.5.5.  Korea

7.5.5.1.  Korea Hepatitis E Diagnostic Tests  Revenue (Millions USD) and Growth Rate (2017-2021)

7.5.6.  India

7.5.6.1.  India Hepatitis E Diagnostic Tests  Revenue (Millions USD) and Growth Rate (2017-2021)

7.5.7.  Southeast Asia

7.5.7.1.  Southeast Asia Hepatitis E Diagnostic Tests  Revenue (Millions USD) and Growth Rate (2017-2021)

7.5.8.  Rest of Asia-Pacific

7.5.8.1.  Rest of Asia-Pacific Hepatitis E Diagnostic Tests  Revenue (Millions USD) and Growth Rate (2017-2021)

7.6.     South America Hepatitis E Diagnostic Tests  by Countries

7.6.1.  South America Hepatitis E Diagnostic Tests  Revenue and Growth Rate (2017-2021)

7.6.2.  South America Hepatitis E Diagnostic Tests  Revenue (Million USD) by Countries (2017-2021)

7.6.3.  Brazil

7.6.3.1.  Brazil Hepatitis E Diagnostic Tests  Revenue (Millions USD) and Growth Rate (2017-2021)

7.6.4.  Argentina

7.6.4.1.  Argentina Hepatitis E Diagnostic Tests  Revenue (Millions USD) and Growth Rate (2017-2021)

7.6.5.  Columbia

7.6.5.1.  Columbia Hepatitis E Diagnostic Tests  Revenue (Millions USD) and Growth Rate (2017-2021)

7.6.6.  Rest of South America

7.6.6.1.  Rest of South America Hepatitis E Diagnostic Tests  Revenue (Millions USD) and Growth Rate (2017-2021)

7.7.     Middle East and Africa Hepatitis E Diagnostic Tests  by Countries

7.7.1.  Middle East and Africa Hepatitis E Diagnostic Tests  Revenue and Growth Rate (2017-2021)

7.7.2.  Middle East and Africa Hepatitis E Diagnostic Tests  Revenue (Million USD) by Countries (2017-2021)

7.7.3.  Saudi Arabia

7.7.3.1.  Saudi Arabia Hepatitis E Diagnostic Tests  Revenue (Millions USD) and Growth Rate (2017-2021)

7.7.4.  United Arab Emirates

7.7.4.1.  United Arab Emirates Hepatitis E Diagnostic Tests  Revenue (Millions USD) and Growth Rate (2017-2021)

7.7.5.  Egypt

7.7.5.1.  Egypt Hepatitis E Diagnostic Tests  Revenue (Millions USD) and Growth Rate (2017-2021)

7.7.6.  Nigeria

7.7.6.1.  Nigeria Hepatitis E Diagnostic Tests  Revenue (Millions USD) and Growth Rate (2017-2021)

7.7.7.  South Africa

7.7.7.1.  South Africa Hepatitis E Diagnostic Tests  Revenue (Millions USD) and Growth Rate (2017-2021)

7.7.8.  Turkey

7.7.8.1.  Turkey Hepatitis E Diagnostic Tests  Revenue (Millions USD) and Growth Rate (2017-2021)

7.7.9.  Rest of Middle East and Africa

7.7.9.1.  Rest of Middle East and Africa Hepatitis E Diagnostic Tests  Revenue (Millions USD) and Growth Rate (2017-2021)

8.       Company Profiles

8.1.     Altona Diagnostics GmbH

8.1.1.  Business Overview

8.1.2.   Service Portfolio

8.1.3.  Strategic Developments

8.1.4.  Financial Overview

8.2.     Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.

8.2.1.  Business Overview

8.2.2.   Service Portfolio

8.2.3.  Strategic Developments

8.2.4.  Financial Overview

8.3.     Biokit S.A.

8.3.1.  Business Overview

8.3.2.   Service Portfolio

8.3.3.  Strategic Developments

8.3.4.  Financial Overview

8.4.     Dia.Pro - Diagnostic Bioprobes s.r.l

8.4.1.  Business Overview

8.4.2.   Service Portfolio

8.4.3.  Strategic Developments

8.4.4.  Financial Overview

8.5.     F. Hoffmann-La Roche Ltd.

8.5.1.  Business Overview

8.5.2.   Service Portfolio

8.5.3.  Strategic Developments

8.5.4.  Financial Overview

8.6.     Fast-track diagnostics Ltd.

8.6.1.  Business Overview

8.6.2.   Service Portfolio

8.6.3.  Strategic Developments

8.6.4.  Financial Overview

8.7.     Fortress Diagnostics Limited

8.7.1.  Business Overview

8.7.2.   Service Portfolio

8.7.3.  Strategic Developments

8.7.4.  Financial Overview

8.8.     Mikrogen GmBH

8.8.1.  Business Overview

8.8.2.   Service Portfolio

8.8.3.  Strategic Developments

8.8.4.  Financial Overview

8.9.     MP Biomedicals

8.9.1.  Business Overview

8.9.2.   Service Portfolio

8.9.3.  Strategic Developments

8.9.4.  Financial Overview

8.10. Primerdesign Ltd

8.10.1.      Business Overview

8.10.2.       Service Portfolio

8.10.3.      Strategic Developments

8.10.4.      Financial Overview

9.       Hepatitis E Diagnostic Tests  Market Forecast (2022-2027)

9.1.     Global Hepatitis E Diagnostic Tests  Revenue (Millions USD) and Growth Rate (2022-2027)

9.2.     Hepatitis E Diagnostic Tests  Market Forecast by Regions (2022-2027)

9.2.1.  North America Hepatitis E Diagnostic Tests  Market Forecast (2022-2027)

9.2.1.1.  United States Hepatitis E Diagnostic Tests  Market Forecast (2022-2027)

9.2.1.2.  Canada Hepatitis E Diagnostic Tests  Market Forecast (2022-2027)

9.2.1.3.  Mexico Hepatitis E Diagnostic Tests  Market Forecast (2022-2027)

9.2.2.  Europe Hepatitis E Diagnostic Tests  Market Forecast (2022-2027)

9.2.2.1.  Germany Hepatitis E Diagnostic Tests  Market Forecast (2022-2027)

9.2.2.2.  France Hepatitis E Diagnostic Tests  Market Forecast (2022-2027)

9.2.2.3.  UK Hepatitis E Diagnostic Tests  Market Forecast (2022-2027)

9.2.2.4.  Russia Hepatitis E Diagnostic Tests  Market Forecast (2022-2027)

9.2.2.5.  Italy Hepatitis E Diagnostic Tests  Market Forecast (2022-2027)

9.2.2.6.  Rest of Europe Hepatitis E Diagnostic Tests  Market Forecast (2022-2027)

9.2.3.  Asia-Pacific Hepatitis E Diagnostic Tests  Market Forecast (2022-2027)

9.2.3.1.  China Hepatitis E Diagnostic Tests  Market Forecast (2022-2027)

9.2.3.2.  Japan Hepatitis E Diagnostic Tests  Market Forecast (2022-2027)

9.2.3.3.  Korea Hepatitis E Diagnostic Tests  Market Forecast (2022-2027)

9.2.3.4.  India Hepatitis E Diagnostic Tests  Market Forecast (2022-2027)

9.2.3.5.  Southeast Asia Hepatitis E Diagnostic Tests  Market Forecast (2022-2027)

9.2.3.6.  Rest of Asia-Pacific Hepatitis E Diagnostic Tests  Market Forecast (2022-2027)

9.2.4.  South America Hepatitis E Diagnostic Tests  Market Forecast (2022-2027)

9.2.4.1.  Brazil Hepatitis E Diagnostic Tests  Market Forecast (2022-2027)

9.2.4.2.  Argentina Hepatitis E Diagnostic Tests  Market Forecast (2022-2027)

9.2.4.3.  Columbia Hepatitis E Diagnostic Tests  Market Forecast (2022-2027)

9.2.4.4.  Rest of South America Hepatitis E Diagnostic Tests  Market Forecast (2022-2027)

9.2.5.  Middle East and Africa Hepatitis E Diagnostic Tests  Market Forecast (2022-2027)

9.2.5.1.  Saudi Arabia Hepatitis E Diagnostic Tests  Market Forecast (2022-2027)

9.2.5.2.  United Arab Emirates Hepatitis E Diagnostic Tests  Market Forecast (2022-2027)

9.2.5.3.  Egypt Hepatitis E Diagnostic Tests  Market Forecast (2022-2027)

9.2.5.4.  Nigeria Hepatitis E Diagnostic Tests  Market Forecast (2022-2027)

9.2.5.5.  South Africa Hepatitis E Diagnostic Tests  Market Forecast (2022-2027)

9.2.5.6.  Turkey Hepatitis E Diagnostic Tests  Market Forecast (2022-2027)

9.2.5.7.  Rest of Middle East and Africa Hepatitis E Diagnostic Tests  Market Forecast (2022-2027)

9.3.     Hepatitis E Diagnostic Tests  Market Forecast by Type (2022-2027)

9.3.1.  Hepatitis E Diagnostic Tests  Forecast by Type (2022-2027)

9.3.2.  Hepatitis E Diagnostic Tests  Market Share Forecast by Type (2022-2027)

9.4.     Hepatitis E Diagnostic Tests  Market Forecast by Applications (2022-2027)

9.4.1.  Hepatitis E Diagnostic Tests  Forecast by Applications (2022-2027)

9.4.2.  Hepatitis E Diagnostic Tests  Market Share Forecast by Applications (2022-2027)


List of Tables

List of Tables and Figures:

Figure United States Hepatitis E Diagnostic Tests Revenue (Million USD) and Growth Rate (2017-2027)
Figure Canada Hepatitis E Diagnostic Tests Revenue (Million USD) and Growth Rate (2017-2027)
Figure Mexico Hepatitis E Diagnostic Tests Revenue (Million USD) and Growth Rate (2017-2027)
Figure Germany Hepatitis E Diagnostic Tests Revenue (Million USD) and Growth Rate (2017-2027)
Figure France Hepatitis E Diagnostic Tests Revenue (Million USD) and Growth Rate (2017-2027)
Figure UK Hepatitis E Diagnostic Tests Revenue (Million USD) and Growth Rate (2017-2027)
Figure Russia Hepatitis E Diagnostic Tests Revenue (Million USD) and Growth Rate (2017-2027)
Figure Italy Hepatitis E Diagnostic Tests Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Europe Hepatitis E Diagnostic Tests Revenue (Million USD) and Growth Rate (2017-2027)
Figure China Hepatitis E Diagnostic Tests Revenue (Million USD) and Growth Rate (2017-2027)
Figure Japan Hepatitis E Diagnostic Tests Revenue (Million USD) and Growth Rate (2017-2027)
Figure Korea Hepatitis E Diagnostic Tests Revenue (Million USD) and Growth Rate (2017-2027)
Figure India Hepatitis E Diagnostic Tests Revenue (Million USD) and Growth Rate (2017-2027)
Figure Southeast Asia Hepatitis E Diagnostic Tests Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Asia-Pacific Hepatitis E Diagnostic Tests Revenue (Million USD) and Growth Rate (2017-2027)
Figure Brazil Hepatitis E Diagnostic Tests Revenue (Million USD) and Growth Rate (2017-2027)
Figure Argentina Hepatitis E Diagnostic Tests Revenue (Million USD) and Growth Rate (2017-2027)
Figure Columbia Hepatitis E Diagnostic Tests Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of South America Hepatitis E Diagnostic Tests Revenue (Million USD) and Growth Rate (2017-2027)
Figure Saudi Arabia Hepatitis E Diagnostic Tests Revenue (Million USD) and Growth Rate (2017-2027)
Figure United Arab Emirates Hepatitis E Diagnostic Tests Revenue (Million USD) and Growth Rate (2017-2027)
Figure Egypt Hepatitis E Diagnostic Tests Revenue (Million USD) and Growth Rate (2017-2027)
Figure Nigeria Hepatitis E Diagnostic Tests Revenue (Million USD) and Growth Rate (2017-2027)
Figure South Africa Hepatitis E Diagnostic Tests Revenue (Million USD) and Growth Rate (2017-2027)
Figure Turkey Hepatitis E Diagnostic Tests Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Middle East and Africa Hepatitis E Diagnostic Tests Revenue (Million USD) and Growth Rate (2017-2027)
Table Global Hepatitis E Diagnostic Tests Revenue and Revenue Share by Type (2017-2019)
Figure Global ELISA HEV IgM Test kits Revenue and Growth Rate (2017-2019)
Figure Global ELISA HEV IgG Test Kits Revenue and Growth Rate (2017-2019)
Figure Global RT-PCR Test Kits Revenue and Growth Rate (2017-2019)
Table Global Hepatitis E Diagnostic Tests Revenue and Revenue Share by Applications (2017-2019)
Figure Global Hospitals Revenue and Growth Rate (2017-2019)
Figure Global Diagnostic Laboratories Revenue and Growth Rate (2017-2019)
Figure Global Research Centers Revenue and Growth Rate (2017-2019)
Figure Global Point of Care Revenue and Growth Rate (2017-2019)
Table Global Hepatitis E Diagnostic Tests Revenue by Regions (2017-2019)
Figure North America Hepatitis E Diagnostic Tests Growth Rate (2017-2019)
Figure North America Hepatitis E Diagnostic Tests Revenue and Growth Rate (2017-2019)
Figure North America Hepatitis E Diagnostic Tests by Countries (2017-2019)
Figure North America Hepatitis E Diagnostic Tests Revenue (Million USD) by Countries (2017-2019)
Figure United States Hepatitis E Diagnostic Tests Growth Rate (2017-2019)
Figure United States Hepatitis E Diagnostic Tests Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Canada Hepatitis E Diagnostic Tests Growth Rate (2017-2019)
Figure Canada Hepatitis E Diagnostic Tests Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Mexico Hepatitis E Diagnostic Tests Growth Rate (2017-2019)
Figure Mexico Hepatitis E Diagnostic Tests Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Europe Hepatitis E Diagnostic Tests Growth Rate (2017-2019)
Figure Europe Hepatitis E Diagnostic Tests Revenue and Growth Rate (2017-2019)
Figure Europe Hepatitis E Diagnostic Tests by Countries (2017-2019)
Figure Europe Hepatitis E Diagnostic Tests Revenue (Million USD) by Countries (2017-2019)
Figure Germany Hepatitis E Diagnostic Tests Growth Rate (2017-2019)
Figure Germany Hepatitis E Diagnostic Tests Revenue (Millions USD) and Growth Rate (2017-2019)
Figure France Hepatitis E Diagnostic Tests Growth Rate (2017-2019)
Figure France Hepatitis E Diagnostic Tests Revenue (Millions USD) and Growth Rate (2017-2019)
Figure UK Hepatitis E Diagnostic Tests Growth Rate (2017-2019)
Figure UK Hepatitis E Diagnostic Tests Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Russia Hepatitis E Diagnostic Tests Growth Rate (2017-2019)
Figure Russia Hepatitis E Diagnostic Tests Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Italy Hepatitis E Diagnostic Tests Growth Rate (2017-2019)
Figure Italy Hepatitis E Diagnostic Tests Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Europe Hepatitis E Diagnostic Tests Growth Rate (2017-2019)
Figure Rest of Europe Hepatitis E Diagnostic Tests Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Asia-Pacific Hepatitis E Diagnostic Tests Growth Rate (2017-2019)
Figure Asia-Pacific Hepatitis E Diagnostic Tests Revenue and Growth Rate (2017-2019)
Figure Asia-Pacific Hepatitis E Diagnostic Tests by Countries (2017-2019)
Figure Asia-Pacific Hepatitis E Diagnostic Tests Revenue (Million USD) by Countries (2017-2019)
Figure China Hepatitis E Diagnostic Tests Growth Rate (2017-2019)
Figure China Hepatitis E Diagnostic Tests Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Japan Hepatitis E Diagnostic Tests Growth Rate (2017-2019)
Figure Japan Hepatitis E Diagnostic Tests Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Korea Hepatitis E Diagnostic Tests Growth Rate (2017-2019)
Figure Korea Hepatitis E Diagnostic Tests Revenue (Millions USD) and Growth Rate (2017-2019)
Figure India Hepatitis E Diagnostic Tests Growth Rate (2017-2019)
Figure India Hepatitis E Diagnostic Tests Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Southeast Asia Hepatitis E Diagnostic Tests Growth Rate (2017-2019)
Figure Southeast Asia Hepatitis E Diagnostic Tests Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Asia-Pacific Hepatitis E Diagnostic Tests Growth Rate (2017-2019)
Figure Rest of Asia-Pacific Hepatitis E Diagnostic Tests Revenue (Millions USD) and Growth Rate (2017-2019)
Figure South America Hepatitis E Diagnostic Tests Growth Rate (2017-2019)
Figure South America Hepatitis E Diagnostic Tests Revenue and Growth Rate (2017-2019)
Figure South America Hepatitis E Diagnostic Tests by Countries (2017-2019)
Figure South America Hepatitis E Diagnostic Tests Revenue (Million USD) by Countries (2017-2019)
Figure Brazil Hepatitis E Diagnostic Tests Growth Rate (2017-2019)
Figure Brazil Hepatitis E Diagnostic Tests Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Argentina Hepatitis E Diagnostic Tests Growth Rate (2017-2019)
Figure Argentina Hepatitis E Diagnostic Tests Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Columbia Hepatitis E Diagnostic Tests Growth Rate (2017-2019)
Figure Columbia Hepatitis E Diagnostic Tests Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of South America Hepatitis E Diagnostic Tests Growth Rate (2017-2019)
Figure Rest of South America Hepatitis E Diagnostic Tests Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Middle East and Africa Hepatitis E Diagnostic Tests Growth Rate (2017-2019)
Figure Middle East and Africa Hepatitis E Diagnostic Tests Revenue and Growth Rate (2017-2019)
Figure Middle East and Africa Hepatitis E Diagnostic Tests by Countries (2017-2019)
Figure Middle East and Africa Hepatitis E Diagnostic Tests Revenue (Million USD) by Countries (2017-2019)
Figure Saudi Arabia Hepatitis E Diagnostic Tests Growth Rate (2017-2019)
Figure Saudi Arabia Hepatitis E Diagnostic Tests Revenue (Millions USD) and Growth Rate (2017-2019)
Figure United Arab Emirates Hepatitis E Diagnostic Tests Growth Rate (2017-2019)
Figure United Arab Emirates Hepatitis E Diagnostic Tests Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Egypt Hepatitis E Diagnostic Tests Growth Rate (2017-2019)
Figure Egypt Hepatitis E Diagnostic Tests Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Nigeria Hepatitis E Diagnostic Tests Growth Rate (2017-2019)
Figure Nigeria Hepatitis E Diagnostic Tests Revenue (Millions USD) and Growth Rate (2017-2019)
Figure South Africa Hepatitis E Diagnostic Tests Growth Rate (2017-2019)
Figure South Africa Hepatitis E Diagnostic Tests Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Turkey Hepatitis E Diagnostic Tests Growth Rate (2017-2019)
Figure Turkey Hepatitis E Diagnostic Tests Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Middle East and Africa Hepatitis E Diagnostic Tests Growth Rate (2017-2019)
Figure Rest of Middle East and Africa Hepatitis E Diagnostic Tests Revenue (Millions USD) and Growth Rate (2017-2019)
Table Altona Diagnostics GmbH Hepatitis E Diagnostic Tests Financial Overview
Table Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. Hepatitis E Diagnostic Tests Financial Overview
Table Biokit S.A. Hepatitis E Diagnostic Tests Financial Overview
Table Dia.Pro - Diagnostic Bioprobes s.r.l Hepatitis E Diagnostic Tests Financial Overview
Table F. Hoffmann-La Roche Ltd. Hepatitis E Diagnostic Tests Financial Overview
Table Fast-track diagnostics Ltd. Hepatitis E Diagnostic Tests Financial Overview
Table Fortress Diagnostics Limited Hepatitis E Diagnostic Tests Financial Overview
Table Mikrogen GmBH Hepatitis E Diagnostic Tests Financial Overview
Table MP Biomedicals Hepatitis E Diagnostic Tests Financial Overview
Table Primerdesign Ltd Hepatitis E Diagnostic Tests Financial Overview
Figure Global Hepatitis E Diagnostic Tests Revenue (Millions USD) and Growth Rate (2019-2027)
Table Hepatitis E Diagnostic Tests Market Forecast by Regions (2019-2027)
Figure North America Hepatitis E Diagnostic Tests Market Forecast (2019-2027)
Figure United States Hepatitis E Diagnostic Tests Market Forecast (2019-2027)
Figure Canada Hepatitis E Diagnostic Tests Market Forecast (2019-2027)
Figure Mexico Hepatitis E Diagnostic Tests Market Forecast (2019-2027)
Figure Europe Hepatitis E Diagnostic Tests Market Forecast (2019-2027)
Figure Germany Hepatitis E Diagnostic Tests Market Forecast (2019-2027)
Figure France Hepatitis E Diagnostic Tests Market Forecast (2019-2027)
Figure UK Hepatitis E Diagnostic Tests Market Forecast (2019-2027)
Figure Russia Hepatitis E Diagnostic Tests Market Forecast (2019-2027)
Figure Italy Hepatitis E Diagnostic Tests Market Forecast (2019-2027)
Figure Rest of Europe Hepatitis E Diagnostic Tests Market Forecast (2019-2027)
Figure Asia-Pacific Hepatitis E Diagnostic Tests Market Forecast (2019-2027)
Figure China Hepatitis E Diagnostic Tests Market Forecast (2019-2027)
Figure Japan Hepatitis E Diagnostic Tests Market Forecast (2019-2027)
Figure Korea Hepatitis E Diagnostic Tests Market Forecast (2019-2027)
Figure India Hepatitis E Diagnostic Tests Market Forecast (2019-2027)
Figure Southeast Asia Hepatitis E Diagnostic Tests Market Forecast (2019-2027)
Figure Rest of Asia-Pacific Hepatitis E Diagnostic Tests Market Forecast (2019-2027)
Figure South America Hepatitis E Diagnostic Tests Market Forecast (2019-2027)
Figure Brazil Hepatitis E Diagnostic Tests Market Forecast (2019-2027)
Figure Argentina Hepatitis E Diagnostic Tests Market Forecast (2019-2027)
Figure Columbia Hepatitis E Diagnostic Tests Market Forecast (2019-2027)
Figure Rest of South America Hepatitis E Diagnostic Tests Market Forecast (2019-2027)
Figure Middle East and Africa Hepatitis E Diagnostic Tests Market Forecast (2019-2027)
Figure Saudi Arabia Hepatitis E Diagnostic Tests Market Forecast (2019-2027)
Figure United Arab Emirates Hepatitis E Diagnostic Tests Market Forecast (2019-2027)
Figure Egypt Hepatitis E Diagnostic Tests Market Forecast (2019-2027)
Figure Nigeria Hepatitis E Diagnostic Tests Market Forecast (2019-2027)
Figure South Africa Hepatitis E Diagnostic Tests Market Forecast (2019-2027)
Figure Turkey Hepatitis E Diagnostic Tests Market Forecast (2019-2027)
Figure Rest of Middle East and Africa Hepatitis E Diagnostic Tests Market Forecast (2019-2027)
Figure Global Hepatitis E Diagnostic Tests Forecast by Type (2019-2027)
Figure Global Hepatitis E Diagnostic Tests Market Share Forecast by Type (2019-2027)
Figure Global Hepatitis E Diagnostic Tests Forecast by Type (2019-2027)
Figure Global Hepatitis E Diagnostic Tests Forecast by Applications (2019-2027)
Figure Global Hepatitis E Diagnostic Tests Market Share Forecast by Applications (2019-2027)
Figure Global Hepatitis E Diagnostic Tests Forecast by Applications (2019-2027)

Please Note: Data related to the Companies are subject to Availability.


Research Methodology

We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.

Data Mining

Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.

Data Collection Matrix

Data Collection Matrix

Supply Side

Demand Side

Primary Data Sources

  • Manufacturers
  • Distributors & Wholesalers
  • GPOs
  • Physicians/Specialist
  • Healthcare Providers
  • Consumers

Secondary Data Sources

  • Annual Reports/SEC Filings/ Investor Presentations/ Press Releases
  • Government/Associations Publications
  • Case Studies
  • Reference Customers

 

Market Modeling and Forecasting

We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.

  • Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
  • Number of patients for particular device or medical procedure and
  • Repeated use of particular device depending on health and condition of patient
  • Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.

We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.

Data Validation

We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.

Data Triangulation

data triangulation

Industry Analysis

Qualitative Data

Quantitative Data (2017-2025)

  • Market Dynamics (Drivers, Restraints, and Challenges)
  • Industry Trend Analysis
  • Market Opportunities
  • Government Policies and Regulations, Patent Analysis, and Reimbursement Policies
  • Porter’s Five Forces and PESTLE Analysis
  • Key Developments and Competitive Landscape
  • Market Assessment and Forecast
  • Market Assessment and Forecast, By Product
  • Market Assessment and Forecast, By Technology
  • Market Assessment and Forecast, By Application
  • Market Assessment and Forecast, By End User
  • Market Assessment and Forecast, By Region/Country

License Type

For Any Assistance

*
*
*
*
*